Science

football images,betfair login,casumo no deposit bonus codes 2019

The Pfizer logo   | Photo Credit: Reuters

Pfizer Inc said on Monday it had dosed the first patient in a trial testing a flu vaccine based on messenger RNA, the same technology used in the COVID-19 shots made by the U.S. drugmaker and BioNTech.,match odd

gangtok casino,The early-stage trial, conducted in the United States, will test the vaccine in healthy adults ages 65- 85.

free ultimate texas holdem practice, "The COVID-19 pandemic allowed us to deliver on the immense scientific opportunity of mRNA. Influenza remains an area where we see a need for vaccines," said Kathrin Jansen, head of vaccine research and development at Pfizer.

The study will test the safety and immune responses of the vaccine, compared to another FDA-approved influenza vaccine.,upp party


Our code of editorial values

This article is closed for comments.
Please Email the Editor

football match today india time, Printable version | Oct 26, 2021 10:24:22 AM | http://fasttag.co.in/sci-tech/science/pfizer-begins-study-of-mrna-flu-vaccine/article36705770.ece

Next Story
webmaps